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Desperate situations require desperate measures: rescuing the
de-arterialized liver
It is thankfully a very rare occurrence when the liver becomes de-arterialized in a manner that will not permit conventional
arterial reconstruction. The two scenarios where this may occur are in early hepatic arterial thrombosis after liver trans-
plantation and in the setting of elective resectional surgery either to deal with arterial complications or where extensive
arterial resection is required to achieve tumour clearance. In such scenarios, loss of the liver arterial supply risks massive
hepatic necrosis and severe biliary injury with stricturing if the patient survives. In this edition of HPB, Bagui et al. from the
Paul Brousse Hospital, describe their experience of portal vein arterialization (PVA) as a rescue procedure for patients in
both of the previously mentioned scenarios. PVA was performed either by performing a direct arterio-portal anastomosis
or by using a synthetic or natural arterial conduit. In this series intrahepatic arterial signals were obtained after the procedure
and early survival was excellent. PVA is however, not without problems and the arterialization results in greatly increased
portal venous pressure with inherent risk of bleeding and late hepatic fibrosis. In the setting of early hepatic artery
thrombosis after liver transplantation, the procedure has obvious utility in converting patients from potentially requiring
emergency re-transplantation or facing death to elective transplant recipients. In the setting of cancer surgery the procedure
must be considered quite differently as the ‘bridge’ element to transplantation is rarely possible. In dealing with serious
arterial complications of cancer surgery, PVA seems a justifiable desperate measure. The question for elective cancer surgery
is whether the outcomes and survival of PVA justify the poor prognosis that tumours with extensive arterial involvement
frequently carry.
Stephen J Wigmore
Isolated Roux loop pancreaticojejunostomy versus pancreaticogastrostomy
after pancreaticoduodenectomy: a prospective randomized study
With a goal of minimizing post operative pancreatic fistula (POPF), what is the best and safest way to reconstruct the left
pancreatic remnant after pancreaticoduodenectomy (PD)? Several safe anastomotic techniques are available and have been
scrutinized and compared for years. Still, no consensus exists. Can isolating the pancreaticojejunostomy (IR-PJ) to its own
Roux limb protect from POPF? Nakeeb et al. from Mansoura, Egypt compared such a technique with pancreaticogastros-
tomy (PG) in a prospective randomized trial of 90 patients over 2.5 years. Theoretically, avoiding bile-induced activation of
pancreatic juices with IR-PJ may be more protective from POPF, the primary outcome of the trial. Secondary outcomes
included operative time, days to oral feeds, postoperative morbidity and mortality, and exocrine and endocrine pancreatic
functions. POPF rates and severity were the same regardless of IR-PJ or PG, but IR-PJ significantly extended operative times
due to the additional enteroenterostomy required. Mortality was high (7.8%) overall, but not different between groups.
Complication rates did not vary either. Perhaps most notably, severe steatorrhea at 1 year post surgery was significantly
higher in PG than IR-PJ patients. There were no subgroup analyses offered, for example, for higher risk patients who can be
identified through contemporary POPF risk scoring.And so, the search continues. Theoretical appeal aside, IR-PJ offers little
to warrant lengthening an already complex operation.
Mark Callery
Intrathecal morphine for patients undergoing liver resection: more to be
gained than lost
In this issue of HPB, Kasivisvanathan et al. describe the outcomes of a single centre observational study comparing epidural
analgesia (TEA group) to intrathecal morphine with fentanyl patient controlled analgesia (ITM with f-PCA group) for
patients undergoing hepatic resection. Although not randomised, the study seemed well conducted with the two groups
comparable, and with important clinical endpoints identified. Those patients receiving ITM with f-PCA were less likely to
require vasopressors and had a lower requirement for post-operative fluids. They subsequently had a reduced overall
hospital stay although their pain control was poorer than the TEA group in the early post-operative period. Many of these
findings are consistent with previous studies including those recently published in HPB, however what is potentially novel
to this paper is the observation of an increased central venous pressure and blood loss in the ITM with f-PCA group. This
increase in blood loss would appear to be clinically relevant in terms of volume with 16/37 patients losing between
500–1000 mls intra-operatively. Yet this did not appear to translate into a detrimental clinical effect as the rate of intraop-
erative and post-operative transfusion seemed equivalent. Similarly, the reduction in pain scores in the first 24 hours
although statistically significant did not appear to be clinically significant as neither decrease was greater than 30 mm on the
VAS score. Thus, it would seem that ITM has a lot to offer and little to lose but for those considering its use, some thought
may need to be given to ways in which the downsides could be offset. Such interventions could potentially include the
addition of pre resection venesection or caval clamping to help lower the CVP, or the addition of wound catheters or
non-steroidal analgesia to help reduce pain in the immediate postoperative period.
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